Wednesday, October 3, 2018

Definiens showcases pharma solutions for immuno-oncology profiling

Tissue Phenomics approach accelerates clinical trial assay development & patient profiling MUNICH, Oct. 3, 2018 /PRNewswire/ -- Definiens, the Tissue Phenomics® company, has announced the first-ever Definiens Insights Forum to be held at their headquarters in Munich, Germany on...




from PR Newswire: //https://ift.tt/2zNgRiC

No comments:

Post a Comment